Tag: Genzyme

A total of 48 posts are filed under Genzyme
Sanofi Genzyme’s Phase 2 Clinical Trial to Evaluate Oral Substrate Reduction Therapy for Gaucher Disease Type 3
Sanofi Genzyme is investigating an orally administered substrate reduction therapy in Gaucher disease type 3 as part of the 2-part LEAP… Continue Reading
Nominate a Lysosomal Hero For the Sanofi Genzyme TORCH Awards
We are proud to announce the first annual Sanofi Genzyme TORCH Awards! The TORCH Awards are your opportunity to recognize individuals of all… Continue Reading
Can This Outsourcing Model Save Health Care?
By Louis Garguilo, Executive Editor, Outsourced Pharma Follow Me On Twitter @Louis_Garguilo   A company has been formed to push aside the… Continue Reading
Have You Met: Genzyme’s Simone Azevedo?
As a TV Producer for Lifetime’s Behind the Mystery: Rare and Genetic, I have the opportunity to speak with some of the leading forces… Continue Reading
BioFlash Reports: Genzyme Execs Cite Two Big Problems Facing Rare Disease Biotechs
Stephanie Okey, the head of Genzyme’srare disease business in North America, likes to tell the story of a patient who came into the… Continue Reading
New RARE Toolkit: Pediatric Palliative Care
Today Global Genes announces its newest educational toolkit on pediatric palliative care. This toolkit, created in partnership with the… Continue Reading
PDL BioPharma Buys Share of Cerdelga Royalties for $65.6M
Source. PDL BioPharma said yesterday it acquired a portion of the University of Michigan (U-M) worldwide royalty interest in Cerdelga™… Continue Reading
1 2 3 7